Contract manufacturing
Stemmatters addresses all manufacturing steps from material reception to the product’s fill and finish, batch release, storage and retrieval, under cGMP compliance. Our quality management system (QMS) ensures complete continuity in the chain of identity and custody, mitigating traceability risk and providing total transparency over our supply chain operations.

Our contract manufacturing services include
Cell banking
Stemmatters develops and implements procedures for the isolation and banking of a wide variety of human cells. We produce well-characterised research- or clinical-grade MCBs and WCBs, stored in vials or bags under vapour-phase liquid nitrogen or in freezers. Our services ensure a sustainable supply of qualified starting material that meets quality specifications, validated through cell characterisation and functional assays.

Advanced therapies
Stemmatters specialises in the manufacturing of advanced therapy medicinal products (ATMPs), including somatic cell therapy medicinal products (SCTMPs) and tissue-engineered products (TEPs). These therapies are produced under validated standard operating procedures (SOPs) and adhere to the regulatory framework of (EC) No. 1394/2007, ensuring compliance and quality at every stage.
Blood-derived biologicals
Stemmatters has valuable experience in the manufacturing of biological products, including blood-derived biologics, exosomes and conditioned media. We have an excellent track record in manufacturing of complex blood-derived biologicals either as medicinal product or non-pharmaceutical/raw materials to support cell culture.
Ready to transform your vision into reality?
Get in touch to learn more about our work and how we can collaborate.